The number of CD34+ cells mobilized into the peripheral blood can predict the quality of subsequent collections.

PBPC were mobilized using a variety of chemotherapy regimens plus G-CSF in a group of 126 consecutive patients. Data are presented that show a close correlation between the number of CD34+ cells mobilized into the peripheral blood (PB) and the number of CD34+ cells subsequently collected by leukapheresis (R = 0.904). On the basis of this correlation, a regression formula was calculated that could give an estimate of the total number of CD34+ cells likely to be collected by leukapheresis from a given number of CD34+ cells per microliter PB. An easy-to-read table has been compiled to show how this type of analysis can be applied to predict the likely dose of CD34+ cells that will be obtained by leukapheresis over a wide range of patient weights.

[1]  K. Schulman,et al.  Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Gratwohl,et al.  Blood and marrow transplantation activity in Europe 1996 , 1998, Bone Marrow Transplantation.

[3]  G. Salles,et al.  High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation , 1998 .

[4]  E. Shpall,et al.  Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. , 1997, Blood.

[5]  E. Ball,et al.  Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation , 1997, Bone Marrow Transplantation.

[6]  D. Huhn,et al.  Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  P. Lacor,et al.  The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. , 1996, Bone marrow transplantation.

[8]  R. Hargreaves,et al.  When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  N. Schmitz,et al.  Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients , 1996, The Lancet.

[10]  L. Schwartzberg,et al.  An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. , 1995, Blood.

[11]  R. Storb,et al.  Factors that influence collection and engraftment of autologous peripheral-blood stem cells. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Hunter,et al.  Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. , 1995, Bone marrow transplantation.

[13]  R. Storb,et al.  Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantation , 1994, British journal of haematology.

[14]  H. Goldschmidt,et al.  Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. , 1994, Blood.

[15]  L. To,et al.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. , 1992, Bone marrow transplantation.

[16]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.